Who is on it, and how far along Every drug ChEMBL records acting on GRIN1, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Small molecule 16 Protein or peptide 2 Other 2 Approved7 Ketamine Ketamine SponsorPH Health ModalitySmall molecule ActionNegative allosteric modulator Open trials408 Esketamine Esketamine SponsorJohnson & Johnson ModalitySmall molecule ActionNegative allosteric modulator Open trials126 Amantadine Amantadine SponsorEndo International ModalitySmall molecule ActionAntagonist Open trials39 Memantine Memantine SponsorAbbVie ModalitySmall molecule ActionNegative allosteric modulator Open trials36 Acamprosate Acamprosate SponsorAbbVie ModalitySmall molecule ActionAntagonist Open trials5 Orphenadrine Orphenadrine SponsorAche Laboratorios Farmaceuticos S.A. ModalitySmall molecule ActionAntagonist Open trials2 Felbamate Felbamate SponsorViatris ModalitySmall molecule ActionAntagonist Open trials0 Phase 34 AV-101 AV-101 SponsorAerovate Therapeutics ModalitySmall molecule ActionAntagonist Open trials0 Neramexane Neramexane SponsorMerz Group ModalitySmall molecule ActionAntagonist Open trials0 Ralfinamide Ralfinamide SponsorNewron Pharmaceuticals SPA ModalitySmall molecule ActionAntagonist Open trials0 Rapastinel Rapastinel SponsorNaurex, Inc, an affiliate of Allergan plc ModalityProtein or peptide ActionPartial agonist Open trials0 Phase 27 Apimostinel Apimostinel SponsorNaurex, Inc, an affiliate of Allergan plc ModalityProtein or peptide ActionPartial agonist Open trials1 Delucemine Delucemine SponsorNot known ModalitySmall molecule ActionAntagonist Open trials0 GW468816 GW468816 SponsorNot known ModalitySmall molecule ActionAntagonist Open trials0 Indantadol Indantadol SponsorVernalis (R&D) Ltd ModalityOther ActionAntagonist Open trials0 Lanicemine Lanicemine SponsorAstraZeneca Pharmaceuticals ModalitySmall molecule ActionBlocker Open trials0 Neboglamine Neboglamine SponsorNot known ModalitySmall molecule ActionPositive allosteric modulator Open trials0 Perzinfotel Perzinfotel SponsorNot known ModalitySmall molecule ActionAntagonist Open trials0 Phase 11 AZD8108 AZD8108 SponsorNot known ModalityOther ActionAntagonist Open trials0 Preclinical or unknown1 CNS-5161 CNS-5161 SponsorNot known ModalitySmall molecule ActionBlocker Open trials0
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 12 of 20 act as: Glutamate [NMDA] receptor antagonist; the rest name their own mechanism. The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 30 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted Esketamine Plus Sirolimus for Adults With Depression Who Have Not Responded to Esketamine Esketamine, Ketamine Phase 2 Not yet recruiting Rodolfo Furlan Damiano Nov 19, 2026 Low vs. High Dose Oral Midazolam-Ketamine for Pediatric IV Cannulation Ketamine Phase 4 Active, not recruiting Ibrahim Elabd Hassan Mohamed Nov 18, 2026 Ketamine for Treatment of Alzheimers Disease Related Depression Ketamine Phase 2 Not yet recruiting Vanderbilt University Medical Center Nov 17, 2026 Intranasal Esketamine-dexmedetomidine Combination in Patients With Postherpetic Neuralgia Esketamine, Ketamine Phase 4 Not yet recruiting Peking University First Hospital Nov 13, 2026 Prolonged Multimodal Analgesia for Postsurgical Pain Esketamine, Ketamine Not applicable Not yet recruiting Beijing Tiantan Hospital Nov 13, 2026 Longitudinal Assessment of Biomarkers Among Patients With MDD Esketamine, Ketamine — Recruiting Massachusetts General Hospital Nov 12, 2026 Exploring Ketamine's Effects on Depression and Anxiety in Adults With Low Vision Ketamine Phase 2 Not yet recruiting Stanford University Nov 12, 2026 Enhancing the Effect of Stellate Ganglion Block in the Treatment of PTSD: Bupivacaine vs Bupivacaine + Ketamine Ketamine Phase 2 Not yet recruiting The Royal's Institute of Mental Health Research Nov 9, 2026 Intranasal Dexmedetomidine-esketamine Combination and Postoperative Cognitive Recovery in Older Patients Esketamine Phase 4 Not yet recruiting Peking University First Hospital Nov 4, 2026 Esketamine Combined With Transcutaneous Electrical Acupoint Stimulation on Postoperative Recovery Quality After Elective Cesarean Section Esketamine Not applicable Not yet recruiting Anhui Provincial Hospital Nov 4, 2026 Evaluation of the Effect of Amantadine in the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients Amantadine Phase 2 Not yet recruiting Al-Azhar University Oct 22, 2026 Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay Esketamine Phase 2 Not yet recruiting University of Sao Paulo Oct 22, 2026 Effect of Low-Dose Esketamine Combined With Dexmedetomidine on the Incidence of Chronic Postsurgical Pain in Patients Undergoing Pancreatic Surgery Esketamine Phase 4 Not yet recruiting Tianjin Medical University Cancer Institute and Hospital Oct 22, 2026 Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury (MEND) Amantadine, Memantine Phase 2 Not yet recruiting Nova Scotia Health Authority Oct 9, 2026 Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression Amantadine, Memantine Early phase 1 Recruiting Mclean Hospital May 1, 2026 A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease Acamprosate Not applicable Not yet recruiting Yale University Apr 28, 2026 Escalating Doses of Memantine in Down Syndrome (MEDS-123) Amantadine, Memantine Phase 1 Not yet recruiting University Hospitals Cleveland Medical Center Apr 15, 2026 SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases Memantine Phase 2 Not yet recruiting National Taiwan University Hospital Apr 1, 2026 Neuroprotection of Memantine and Rosuvastatin Amantadine, Memantine Phase 2 / Phase 3 Not yet recruiting Tanta University Mar 31, 2026 Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain Amantadine, Memantine Phase 2 Recruiting The University of Texas Health Science Center at San Antonio Mar 13, 2026 Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome Amantadine Not applicable Recruiting Cairo University Feb 19, 2026 Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia Amantadine, Memantine Phase 3 Recruiting Bigespas LTD Nov 26, 2025 Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial) Memantine Phase 2 Recruiting Case Comprehensive Cancer Center Nov 25, 2025 Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) Acamprosate Phase 1 Recruiting National Institute of Neurological Disorders and Stroke (NINDS) Oct 3, 2025 Effectiveness of Chlorzoxazone Versus Orphenadrine Citrate in Alleviating Bruxism Pain Orphenadrine Phase 4 Recruiting University of Baghdad Aug 7, 2025 Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial Acamprosate Phase 2 Recruiting Samer Gawrieh Jul 11, 2025 Apimostinel + Automated Neurocognitive Training for Depression Apimostinel Phase 2 Recruiting Rebecca Price May 6, 2024 Combining a Smartphone App With Medications to Manage Heavy Drinking Acamprosate Not applicable Recruiting VA Office of Research and Development Mar 12, 2024 Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder Acamprosate Phase 4 Recruiting National Institute on Alcohol Abuse and Alcoholism (NIAAA) Feb 21, 2024 Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis Orphenadrine Phase 3 Recruiting Sherief Abd-Elsalam Apr 22, 2015
Show all 30Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2094124 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-21. ChEMBL and Open Targets